Literature DB >> 11062163

High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China.

J Huang1, N Hu, A M Goldstein, M R Emmert-Buck, Z Z Tang, M J Roth, Q H Wang, S M Dawsey, X Y Han, T Ding, G Li, C Giffen, P R Taylor.   

Abstract

Allelic loss on chromosome 17p has been reported frequently in esophageal squamous cell carcinoma (ESCC) and generally encompasses the p53 locus at 17p13.1. However, a good correlation between allelic loss on 17p and mutation of p53 has not been found. This suggests the possibility that unknown tumor suppressor genes near p53 may be involved in the development of ESCC. To evaluate this possibility, we analyzed 30 microsatellite markers covering the entire short arm of chromosome 17 in 56 ESCC patients from a high risk population in northern China, including 34 with a family history of upper gastrointestinal (UGI) cancer and 22 without a family history of any cancer. Cancer lifestyle risk factors and clinical/pathological characteristics were also collected. We found frequent allelic loss (>/=65%) at 28 of the 30 markers evaluated in these ESCC patients. The highest frequencies of allelic loss (> or =80%) were found in three smaller regions: deletion region I located at 17p13.3-p13.2 (between D17S849 and D17S1828); deletion region II located at 17p13.2-p13.1 (between D13S938 and TP53); deletion region III located at 17p13.1-p12 (between D17S804 and D17S799). A number of genes have already been identified in these deleted regions, including: OVCA1, OVCA2 and HIC-1 in deletion region I; p53 in deletion region II; ZNF18, ZNF29, ALDH3 and ALDH10 in deletion region III. These results will help us direct future testing of candidate genes and narrow the search region for major new tumor suppressor genes that may play a role in the pathogenesis of ESCC.

Entities:  

Mesh:

Year:  2000        PMID: 11062163     DOI: 10.1093/carcin/21.11.2019

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

Review 1.  HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.

Authors:  Capucine Fleuriel; Majid Touka; Gaylor Boulay; Cateline Guérardel; Brian R Rood; Dominique Leprince
Journal:  Int J Biochem Cell Biol       Date:  2008-08-03       Impact factor: 5.085

2.  RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer.

Authors:  Li Fu; Yan-Ru Qin; Xiao-Yan Ming; Xian-Bo Zuo; Yu-Wen Diao; Li-Yi Zhang; Jiaoyu Ai; Bei-Lei Liu; Tu-Xiong Huang; Ting-Ting Cao; Bin-Bin Tan; Di Xiang; Chui-Mian Zeng; Jing Gong; Qiangfeng Zhang; Sui-Sui Dong; Juan Chen; Haibo Liu; Jian-Lin Wu; Robert Z Qi; Dan Xie; Li-Dong Wang; Xin-Yuan Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

3.  Crystal structure of yeast YHR049W/FSH1, a member of the serine hydrolase family.

Authors:  Sophie Quevillon-Cheruel; Nicolas Leulliot; Marc Graille; Nadège Hervouet; Frank Coste; Hélène Bénédetti; Charles Zelwer; Joel Janin; Herman Van Tilbeurgh
Journal:  Protein Sci       Date:  2005-03-31       Impact factor: 6.725

4.  Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.

Authors:  Jianghua Zheng; Dan Xiong; Xueqing Sun; Jinglong Wang; Mingang Hao; Tao Ding; Gang Xiao; Xiumin Wang; Yan Mao; Yuejie Fu; Kunwei Shen; Jianhua Wang
Journal:  Cancer Microenviron       Date:  2012-04-13

5.  Genome-Wide CRISPR Screening Identifies the Tumor Suppressor Candidate OVCA2 As a Determinant of Tolerance to Acetaldehyde.

Authors:  Amin Sobh; Alex Loguinov; Alessia Stornetta; Silvia Balbo; Abderrahmane Tagmount; Luoping Zhang; Chris D Vulpe
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

6.  Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Gaohua Han; Ye Tian; Bensong Duan; Haihui Sheng; Hengjun Gao; Junxing Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 7.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

8.  Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China.

Authors:  Nan Hu; Chaoyu Wang; David Ng; Robert Clifford; Howard H Yang; Ze-Zhong Tang; Quan-Hong Wang; Xiao-You Han; Carol Giffen; Alisa M Goldstein; Philip R Taylor; Maxwell P Lee
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

9.  Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.

Authors:  Nan Hu; Robert J Clifford; Howard H Yang; Chaoyu Wang; Alisa M Goldstein; Ti Ding; Philip R Taylor; Maxwell P Lee
Journal:  BMC Genomics       Date:  2010-10-18       Impact factor: 3.969

10.  Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma.

Authors:  Wusheng Yan; Joanna H Shih; Jaime Rodriguez-Canales; Michael A Tangrea; Kris Ylaya; Jason Hipp; Audrey Player; Nan Hu; Alisa M Goldstein; Philip R Taylor; Michael R Emmert-Buck; Heidi S Erickson
Journal:  BMC Res Notes       Date:  2012-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.